Medline, Inc. Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Medline, Inc. holds $39.0B in total assets. Shareholders' equity is $11.3B against $12.6B in total debt. Cash and equivalents total $2.2B. The current ratio is 4.41 and debt-to-equity is 1.11. Based on the Q1 2026 filing.

Total Assets$39.0B Total Stockholders Equity$11.3B Long Term Debt$12.5B Cash And Equivalents$2.2B Total Current Assets$11.2B Total Current Liabilities$2.5B

Latest FilingQ1 2026

Report Date2026-05-06

Market Cap$32.9B

P/E Ratio39.08

ROE7.65%

Current Liabilities

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q4 '25	Q1 '26
Accounts payable	$26.5M	$26.5M	$869.0M	$35.0M	$961.0M	$932.0M
Accrued compensation	—	—	—	—	$323.0M	$303.0M
Accrued expenses	—	—	$1.5B	—	$1.5B	$1.5B
Accrued interest	—	—	—	—	$144.0M	$237.0M
Other Commercial Liabilities	—	—	$1.5B	—	$1.5B	$1.5B
Convertible Debt - Current	—	—	$366.0M	$368.0M	—	—
Accrued Income Taxes, Current	—	—	—	—	$24.0M	$36.0M
Accrued Liabilities, Current	—	—	$1.5B	—	$1.5B	$1.5B
Current portion of long-term debt	—	—	$2.0M	—	$1.0M	$1.0M
Income taxes payable	—	—	—	—	$24.0M	$36.0M
Operating lease liabilities, current	—	—	$76.0M	—	$66.0M	$65.0M
Short-term borrowings	—	—	$2.0M	—	$1.0M	$1.0M
Total current liabilities	—	—	$2.4B	—	$2.5B	$2.5B

Current Assets

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q4 '25	Q1 '26
Accounts receivable, net	$64.0M	$64.0M	$3.2B	$98.0M	$3.5B	$3.7B
Allowance for Doubtful Accounts	—	—	—	—	$152.0M	$148.0M
Allowance for Doubtful Accounts Receivable (Current)	—	—	—	—	$152.0M	$148.0M
Cash and cash equivalents	—	—	$250.0M	$840.0M	$1.9B	$2.2B
Finished goods	—	—	—	—	$4.0B	$4.0B
Work in process and raw materials	—	—	—	—	$748.0M	$835.0M
Other current assets	—	—	$398.0M	—	$438.0M	$463.0M
Finished goods	—	—	—	—	$4.0B	$4.0B
Raw materials	—	—	—	—	$748.0M	$835.0M
Inventories	$136.3M	$136.3M	$4.5B	-$71.0M	$4.8B	$4.8B
Inventory LIFO Reserve	—	—	—	—	$359.0M	$388.0M
Other Inventory, Net	—	—	—	—	$44.0M	$56.0M
Prepaid expenses and other current assets	—	—	$398.0M	—	$438.0M	$463.0M
Restricted cash	—	—	—	—	$3.0M	$2.0M
Total current assets	—	—	$8.3B	—	$10.7B	$11.2B

Equity

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q4 '25	Q1 '26
Additional paid-in capital	—	—	—	—	$10.7B	$11.1B
Accumulated other comprehensive income (loss)	—	—	$11.0M	—	$27.0M	$18.0M
Common Stock Shares Outstanding	—	—	—	—	—	$84.0M
Convertible Preferred Stock Authorized Shares	—	—	—	—	5B	5B
Convertible Preferred Stock Issued Shares	—	—	—	—	0	0
Convertible Preferred Stock Outstanding Shares	—	—	—	—	0	0
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	—	—	—	—	$0.0	$0.0
Noncontrolling interests	—	—	—	—	$8.5B	$8.1B
Number of Exercisable Options	—	—	—	—	—	0
Number of Vested and Expected to Vest Options	—	—	—	—	—	$84.0M
Preferred stock	—	—	—	—	$0.0	$0.0
Preferred Stock Par Value Per Share	—	—	—	—	$0.00	$0.00
Retained earnings	—	—	—	—	-$7.0M	$122.0M
Share-Based Payment Award Options Outstanding - Number	—	—	—	—	6.8M	6.8M
Share-Based Payment - Unrecognized Cost of Nonvested Awards	—	—	—	—	—	$20.0M
Temporary Equity Attributable to Parent	—	—	$366.0M	$368.0M	—	—
Total liabilities and stockholders' equity	—	—	$36.0B	—	$38.5B	$39.0B
Total stockholders' equity	—	—	—	—	$10.7B	$11.3B
Weighted Average Exercise Price of Outstanding Options	—	—	—	—	$29.00	$29.00
Weighted Average Exercise Price of Vested and Expected to Vest Options	—	—	—	—	—	$29.00

Non-Current Liabilities

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q4 '25	Q1 '26
Contingent Consideration Liability (Non-Current)	—	—	—	—	$29.0M	$29.0M
Debt Maturity - 2024	—	—	—	—	—	$76.0M
Debt Maturity - 2027	—	—	—	—	—	$8.5B
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	—	—	—	—	$195.0M	$184.0M
Long-term debt	—	—	$16.4B	—	$12.5B	$12.5B
Operating Lease Liabilities (Total)	—	—	$405.0M	—	$452.0M	—
Other non-current liabilities	—	—	$598.0M	—	$682.0M	$625.0M
Total Carrying Value of Debt	—	—	—	—	$12.8B	$12.8B
Total liabilities	—	—	$19.5B	—	$29.0M	$29.0M
Total noncurrent liabilities	—	—	$17.0B	—	$16.7B	$17.1B

Non-Current Assets

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q4 '25	Q1 '26
Deferred tax assets	-$6.0M	-$6.0M	$0.0	-$4.0M	$583.0M	$837.0M
Deferred Tax Assets and Other Non-Current Assets	—	—	$23.1B	—	$23.0B	$23.1B
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	—	—	—	—	—	$701.0M
Finite Lived Intangible Assets - Gross	—	—	—	—	$12.9B	$12.9B
Goodwill	—	—	$8.1B	—	$8.1B	$8.1B
Intangible Assets Gross (Excluding Goodwill)	—	—	—	—	$16.7B	$16.7B
Intangible assets, net	—	—	$14.6B	—	$13.9B	$9.9B
Deferred tax assets	—	—	$0.0	—	$583.0M	$837.0M
Intangible assets — net	—	—	—	—	$10.1B	$9.9B
Other intangible assets—net	—	—	$14.6B	—	$13.9B	$13.7B
Other non-current assets	—	—	$23.1B	—	$23.0B	$23.1B
Other non-current assets	—	—	$487.0M	—	$472.0M	$446.0M
Accumulated depreciation	—	—	—	—	$2.8B	$3.0B
Property and equipment, net	—	—	$4.6B	—	$4.8B	$4.8B
Software and Technology Licenses, Net	—	—	$23.1B	—	$23.0B	$23.1B
Total assets	—	—	$36.0B	—	$38.5B	$39.0B

Other

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q4 '25	Q1 '26
Other taxes payable	—	—	—	—	$87.0M	$85.0M
Customer rebates and distributor chargebacks	—	—	—	—	$406.0M	$401.0M
Allowance for doubtful accounts	—	—	—	—	$152.0M	$148.0M
Business Combination, Contingent Consideration, Liability	—	—	—	—	$29.0M	$29.0M
Short-term debt and current portion of long-term debt	—	—	$78.0M	—	$77.0M	$77.0M
Long-term debt, gross	—	—	—	—	$12.8B	$12.8B
Debt Issuance Costs, Net	—	—	—	—	$195.0M	$184.0M
Deferred tax asset, tax receivable agreement	—	—	—	—	—	$294.0M
Notional amount, annual incremental decrease	—	—	$500.0M	—	$500.0M	—
Cost not yet recognized	—	—	—	—	—	$20.0M
Estimated excess of current replacement cost over LIFO cost of inventories	—	—	—	—	$359.0M	$388.0M
Thereafter	—	—	—	—	—	$6.5B
Finite-Lived Intangible Assets, Accumulated Amortization	—	—	—	—	$2.8B	$3.0B
2028	—	—	—	—	—	$704.0M
2030	—	—	—	—	—	$701.0M
Remainder of 2026	—	—	—	—	—	$528.0M
2027	—	—	—	—	—	$704.0M
2029	—	—	—	—	—	$702.0M
Gross Carrying Amount	—	—	—	—	$12.9B	$12.9B
Indefinite- lived intangible impairment	—	—	—	—	$16.7B	$16.7B
Limited Partners Capital Account	—	—	$16.1B	—	—	—
2028	—	—	—	—	—	$726.0M
2029	—	—	—	—	—	$8.5B
2030	—	—	—	—	—	$3.3B
2027	—	—	—	—	—	$76.0M
Remainder of 2026	—	—	—	—	—	$76.0M
Noncontrolling interests in subsidiaries	—	—	—	—	$8.5B	$8.1B
Long-Lived Assets	—	—	—	—	$5.2B	$5.2B
Number of classes	—	—	—	—	3.00	3.00
Number of third-party suppliers	—	—	—	—	—	1300.00
Other accrued liabilities	—	—	—	—	$402.0M	$400.0M
Partners Capital	—	—	$16.2B	$16.5B	$16.9B	—
Preferred Stock, Par or Stated Value Per Share	—	—	—	—	$0.0	$0.0
Preferred Stock, Shares Authorized	—	—	—	—	$5.0B	$5.0B
Preferred Stock, Shares Issued	—	—	—	—	$0.0	$0.0
Preferred Stock, Shares Outstanding	—	—	—	—	$0.0	$0.0
Recorded Unconditional Purchase Obligation	—	—	—	—	—	$805.0M
2024	—	—	—	—	—	$169.0M
2025	—	—	—	—	—	$172.0M
2026	—	—	—	—	—	$115.0M
Recorded Unconditional Purchase Obligation, Due in Remainder of Fiscal Year	—	—	—	—	—	$128.0M
2023	—	—	—	—	—	$162.0M
Thereafter	—	—	—	—	—	$59.0M
Sale of stock, price per share (in dollars per share)	—	—	—	—	—	$41.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	—	—	—	—	—	$29.0
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	—	—	—	—	—	$0.0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	—	—	—	—	$6.8M	$6.8M
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	—	—	—	—	—	$6.8M
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	—	—	—	—	—	$84.0M
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	—	—	—	—	$29.0	$29.0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	—	—	—	—	—	$84.0M
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	—	—	—	—	—	$0.0
Expected to vest (in dollars per share)	—	—	—	—	—	$11.97
Exercisable (in dollars per share)	—	—	—	—	—	$0.00
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price	—	—	—	—	$11.97	$11.97
Tax receivable agreement liability	—	—	$0.0	—	$3.5B	$4.0B
Tax receivable agreement liability, current	—	—	—	—	—	$12.0M
Tax receivable agreement liability	—	—	—	—	$3.5B	$4.0B
Remainder of Fiscal Year 2024	—	—	—	—	—	$76.0M
Remainder of Fiscal Year 2025	—	—	—	—	—	$528.0M
Unrecorded Unconditional Purchase Obligation	—	—	—	—	—	$162.0M
Unrecorded Unconditional Purchase Obligation - Due Year Two	—	—	—	—	—	$169.0M
Unrecorded Unconditional Purchase Obligation - Due Year Three	—	—	—	—	—	$172.0M
Unrecorded Unconditional Purchase Obligation - Due Year Four	—	—	—	—	—	$115.0M